Completed NA INTERVENTIONAL 2-arm NCT01019668

Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy

Sponsor: Shin Kong Wu Ho-Su Memorial Hospital

Conditions Central Serous Chorioretinopathy

Interventions Verteporfin PDT, half-dose verteporfin PDT, half-fluence

Updated 5 times since 2017 Last updated: Jul 22, 2011 Started: Nov 30, 2008 Primary completion: Dec 31, 2009 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Central Serous Chorioretinopathy, this trial is completed. The trial is conducted by Shin Kong Wu Ho-Su Memorial Hospital and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shin Kong Wu Ho-Su Memorial Hospital

Data source: Shin Kong Wu Ho-Su Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan